Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis
PaperCitations, authors & open-access status
A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 130 citations, 2018 year and green oa status.
130
Citations
2018
Year
green
OA Status